The Newcastle Therapeutic Tolerance Workshop brings together leading researchers and industry experts to discuss the latest advances in immune tolerance.
Topas Therapeutics is contributing to the scientific program with two presentations: Sabine Fleischer, MD, Head of Translational Medicine, will present on tolerance spreading induced by our nanoparticle platform and its potential to improve gene therapy outcomes. Cristina de Min, MD, Chief Medical Officer, will present on targeting liver sinusoidal endothelial cells (LSECs) to drive precise, antigen-specific immune tolerance for autoimmune diseases.
The workshop takes place in Newcastle upon Tyne, UK, from June 29 to July 3, 2026.
